Time Course of Neutralizing Antibody in Health Care Workers With Mild or Asymptomatic COVID-19 Infection.
SARS-CoV-2
follow-up
health care workers
mild or asymptomatic infection
neutralizing antibody titer
Journal
Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
received:
18
03
2021
accepted:
09
06
2021
entrez:
23
7
2021
pubmed:
24
7
2021
medline:
24
7
2021
Statut:
epublish
Résumé
We describe the time course of neutralizing antibody (NtAb) titer in a cohort of health care workers with mild or asymptomatic severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection. NtAb levels decreased over time; however, serum neutralizing activity remained detectable after a median of 7 months from SARS-CoV-2 diagnosis in the majority of cases.
Identifiants
pubmed: 34295945
doi: 10.1093/ofid/ofab312
pii: ofab312
pmc: PMC8291533
doi:
Types de publication
Journal Article
Langues
eng
Pagination
ofab312Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Références
BMC Pulm Med. 2020 Jul 29;20(1):203
pubmed: 32727446
J Public Health (Oxf). 2021 Apr 12;43(1):26-34
pubmed: 33140084
Clin Microbiol Infect. 2021 Mar;27(3):389-395
pubmed: 33359375
Nature. 2021 Mar;591(7851):639-644
pubmed: 33461210
Influenza Other Respir Viruses. 2020 Mar;14(2):237-243
pubmed: 31837101
Science. 2020 Aug 14;369(6505):806-811
pubmed: 32434945
JAMA Intern Med. 2020 Oct 1;180(10):1356-1362
pubmed: 32808970
J Infect Dis. 2021 Jan 4;223(1):47-55
pubmed: 33104179
Science. 2021 Feb 5;371(6529):
pubmed: 33408181
Sci Immunol. 2020 Dec 23;5(54):
pubmed: 33361161
Front Oncol. 2020 Aug 18;10:1574
pubmed: 33014806
Lancet Public Health. 2020 Sep;5(9):e475-e483
pubmed: 32745512
Front Immunol. 2021 Jan 29;11:628971
pubmed: 33584731
Nat Commun. 2021 Feb 8;12(1):844
pubmed: 33558507
Nat Commun. 2020 Sep 17;11(1):4704
pubmed: 32943637
Annu Rev Immunol. 2003;21:515-46
pubmed: 12500980
Int J Infect Dis. 2021 Jul;108:176-178
pubmed: 34022329
BMJ Open Respir Res. 2021 Sep;8(1):
pubmed: 34561239